Evidence map›Paper›PMID 32433254›Full record

ReviewInternational clinical psychopharmacology2020

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders.

Naomi A Fineberg, Eric Hollander, Stefano Pallanti, Susanne Walitza, Edna Grünblatt, Bernardo Maria Dell'Osso, Umberto Albert, Daniel A Geller, Vlasios Brakoulias, Y C Janardhan Reddy and 16 more

Registry-linked trialOpen access · greenAbstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in International clinical psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05841017 (Effectiveness of the Immersive Virtual Reality in the Psychological Treatment of Obsessive Compulsive Disorder), which is not on this map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05841017 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Effectiveness of the Immersive Virtual Reality in the Psychological Treatment of Obsessive Compulsive Disorder

TypeinterventionalSponsorConsorci Hospitalari de VicRan2023 to 2024Enrolled98ConditionsObsessive-Compulsive DisorderArmsPsychotherapy with Immersive Virtual Reality support.
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 11 countries.

Naomi A FinebergUniversity of Hertfordshire, Hatfield.
Eric HollanderDepartment of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
Stefano PallantiIstituto di Neuroscienze, University of Florence, Firenze, Italy.
Susanne WalitzaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich.
Edna GrünblattDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich.
Bernardo Maria Dell'OssoUniversity of Milan, Department of Biomedical and Clinical Sciences Luigi Sacco, Ospedale Sacco-Polo Universitario, ASST Fatebenefratelli-Sacco, Milan, Italy.
Umberto AlbertDepartment of Medicine, Surgery and Health Sciences, UCO Clinica Psichiatrica, University of Trieste, Trieste, Italy.
Daniel A GellerDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Vlasios BrakouliasWestern Sydney Obsessive-Compulsive and Related Disorders Service, Western Sydney Local Health District, Blacktown Hospital, Blacktown, New South Wales.
Y C Janardhan ReddyOCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India.
Shyam Sundar ArumughamOCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India.
Roseli G ShavittOCD Spectrum Disorders Program, Institute and Department of Psychiatry, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo-SP, Brazil.
Lynne DrummondConsultant Psychiatrist, SW London and St George's NHS Trust and St George's, University of London, London.
Benedetta GranciniHertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire.
Vera De CarloHertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire.
Eduardo CinosiUniversity of Hertfordshire, Hatfield.
Samuel R ChamberlainDepartment of Psychiatry, University of Cambridge, Cambridge.
Konstantinos IoannidisDepartment of Psychiatry, University of Cambridge, Cambridge.
Carolyn I RodriguezDepartment of Psychiatry and Behavioural Sciences, Stanford University, California, USA.
Kabir GargHertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire.
David CastleSt. Vincent's Hospital Melbourne and The University of Melbourne, Melbourne, Australia.
Michael Van AmeringenDepartment of Psychiatry and Behavioural Neurosciences, McMaster University.
Dan J SteinSA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Lior CarmiThe Post Trauma Center, Chaim Sheba Medical Center, Ramat Gan.
Joseph ZoharThe Post Trauma Center, Chaim Sheba Medical Center, Ramat Gan.
Jose M MenchonDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, University of Barcelona, Cibersam, Barcelona, Spain.
ASST Fatebenefratelli Sacco · ITHertfordshire Partnership University NHS Foundation Trust · GBNational Institute of Mental Health and Neurosciences · INCambridgeshire and Peterborough NHS Foundation Trust · GBHamilton Health Sciences · CAHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRMassachusetts General Hospital · USMontefiore Medical Center · USSheba Medical Center · ILSouth African Medical Research Council · ZAStanford University · USSt George's, University of London · GBSwiss Integrative Center for Human Health · CHTel Aviv University · ILThe University of Melbourne · AUTranslational Research Institute · AUUniversitat de Barcelona · ESUniversity Hospital of Zurich · CHUniversity of Cambridge · GBUniversity of Florence · IT

Funding

Department of Health PB-PG-0712-28044Department of Health PB-PG-1216-20005Wellcome Trust
6 · The paper itself

Abstract

In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.

Indexed as

Societies, ScientificEvidence-Based MedicineHumansObsessive-Compulsive Disorder

Identifiers

PMID32433254
PMCPMC7255490
OpenAlexW3027044460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.